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The combination of the powerful antimicrobial agent florfenicol and the nonsteroidal anti-inflammatory flunixinmeglumine is used
for the treatment of bovine respiratory disease (BRD) and control of BRD-associated pyrexia, in beef and nonlactating dairy cattle.
This study describes the development and validation of anHPLC-UVmethod for the simultaneous determination of florfenicol and
flunixin, in an injectable preparation with a mixture of excipients. The proposed RP-HPLC method was developed by a reversed
phase- (RP-) C18e (250mm × 4.6mm, 5 𝜇m) column at room temperature, with an isocratic mobile phase of acetonitrile and water
mixture, and pH was adjusted to 2.8 using diluted phosphoric acid, a flow rate of 1.0mL/min, and ultraviolet detection at 268 nm.
The stability-indicating method was developed by exposing the drugs to stress conditions of acid and base hydrolysis, oxidation,
photodegradation, and thermal degradation; the obtained degraded products were successfully separated from the APIs. This
method was validated in accordance with FDA and ICH guidelines and showed excellent linearity, accuracy, precision, specificity,
robustness, LOD, LOQ, and system suitability results within the acceptance criteria.
1. Introduction
Florfenicol and flunixinmeglumine combination (Flr&Flx) is
an effective antimicrobial andnonsteroidal anti-inflammatory
for veterinary use, indicated for treatment of bovine respira-
tory disease (BRD) associated withMannheimia haemolytica,
Pasteurella multocida, Histophilus somni, and Mycoplasma
bovis, and control of BRD-associated pyrexia in beef and
nonlactating dairy cattle.
Florfenicol is a broad-spectrum, primarily bacteriostatic
antibiotic, effective againstwide range of pathogenic strains of
microorganisms including many Gram-negative and Gram-
positive bacteria [1].
Flunixin is cyclooxygenase inhibitor analgesic anti-
inflammatory used to reduce the hemodynamic inflamma-
tion caused by endotoxin and to reduce mortality associated
with endotoxemic shock [2, 3]. The structure of florfenicol
and flunixin is shown in Figure 1.
By reviewing the literature, there are many analytical
methods for individual determination of Flr or Flx or in
combination with other drugs in a pharmaceutical formula-
tion, but none of these methods include stability-indicating
analytical method for the simultaneous determination of
both Flr and Flx, in the presence of degradation materials
[4–11]. The objective of this study is therefore to develop and
validate a simple and fast RP-HPLC method using UV-PDA
detector to simultaneously quantify florfenicol andflunixin in
amedicinal formulation.Thedevelopedmethod is a validated
stability-indicating method, which provides a high degree of
analytical confidence that it can be used for the assay test of
both active ingredients in a single run and can specifically
detect any potential degradants that may produce during
stability testing or during product shelf life. This method was
validated in accordance with the requirements of FDA, ICH,
and USP guidelines [12–16].
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Figure 1: Chemical structure of florfenicol and flunixin meglumine.
Table 1: HPLC chromatographic conditions of the current method.
Chromatographic conditions
Flow rate 1.0mL/min
Wavelength (𝜆) 268 nm
Stationary phase RP18e, 5 𝜇m, 250 × 4.6mm
Column temperature 25∘C
Injection volume 20 𝜇L
Run time 10 minutes
2. Materials and Methods
2.1. Instrumentation. Liquid chromatography method devel-
opment and validation analysis were conducted using
Dionex-Ultimate 3000 HPLC system, equipped with LPG-
3400SD pump, WPS-3000SL autosampler, TCC-3000 col-
umn oven, DAD-3000 UV–VIS diode array detector, and
Phenomenex Luna C18 (5𝜇m × 25 cm × 4.6mm id) column.
Chromeleon Data system Software (Version 6.80 DU10A
Build 2826 (171948)) was used for data processing and
evaluation. The used double-distilled water was prepared by
Aquatron equipment model A 4000D.
2.2. Chemicals and Reagents. Active materials, florfenicol
and flunixin meglumine, working reference standards with a
purity of (>99%) were purchased from Sigma Aldrich. The
finished injectable solution samples and all active materials
and excipients were gifted by the Advanced Veterinary Man-
ufacturing Company (Palestine).The acetonitrile used was of
HPLC grade and water was obtained by double distillation.
Other reagents such as phosphoric acid, hydrochloric acid,
sodium hydroxide, and hydrogen peroxide were purchased
fromMerck and Sigma Aldrich.
2.3. Chromatographic Conditions. Mobile phase was pre-
pared by mixing 600mL acetonitrile with 400mL of water
and then adjusted to pH 2.8 using 2M phosphoric acid. The
chromatographic conditions were run as shown in Table 1.
2.4. Preparation of Standard Solutions. A standard solu-
tion of florfenicol (1.2mg/mL) and flunixin meglumine
(0.1096mg/mL) was prepared by dissolving an accurately
weighed amount of florfenicol 300mg and 27.4mg of flunixin
meglumine in 50mL of mobile phase, and then 5mL of the
resulting solution was diluted to 25mL by the same solvent.
Table 2: Stress conditions applied for drug substance and drug
product.
Stress type Conditions Time
Acid hydrolysis 1 N HCl; at 40∘C 2 days
Base hydrolysis 0.02N NaOH; at RT 2 hours
Oxidative/solution 0.2% H2O2 at 40
∘C;
protected from light 7 days
Thermal 75∘C 14 days
Photodegradation UV light 3 days
2.5. Preparation of Sample Solution. A sample solution was
prepared with a concentration equivalent to that in standard
solution by transferring 1mL of the drug injectable solution,
which contains 300mg of florfenicol and 27.4mg of flunixin
meglumine, with about 40mL of the mobile phase into a
50mL volumetric flask; the volume was completed to mark
by the same solvent, and then 5mL of the resulting solution
was diluted to 25mL by the same solvent.
2.6. Method Validation. The method was validated as per
ICH and FDA guidelines for specificity, linearity and range,
accuracy, precision, LOQ, LOD, and robustness [12, 15].
2.6.1. Specificity. Forced degradation study was conducted by
exposing samples of the drug substance and drug product
to various stress conditions of hydrolysis, oxidation, photo-
degradation, and thermal stress; the time and conditions are
illustrated in Table 2. Stressed samples were analyzed occa-
sionally; related peaks were checked for the retention times,
peaks interference, spectra purity, and separation factors.
2.6.2. Linearity. To evaluate linearity and range of the
method, seven different concentrations of florfenicol (480,
720, 960, 1200, 1440, 1680, and 1920 𝜇g/mL) andflunixinmeg-
lumine (43.8, 65.8, 87.7, 109.6, 131.5, 153.4, and 175.4 𝜇g/mL)
were prepared. Three injections from each concentration
were analyzed under the same conditions.
2.6.3. Accuracy. The accuracy of the assay method was per-
formed on three spiked concentration levels (80%, 100%, and
120%) around the test concentration (florfenicol 1200𝜇g/mL
and flunixin meglumine 109.6 𝜇g/mL), by nine determina-
tions (three replicates of each concentration).The percentage
recovery and RSD were calculated for each of the replicate
samples.
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2.6.4. Precision. Precision was performed at two levels,
repeatability and intermediate precision. Repeatability, or
method precision, was established by six assay determina-
tions at the 100% concentration levels on the same day.
The RSD of obtained results was calculated to evaluate
repeatability results.
Intermediate precision or ruggedness was established by
doing repeatability test by another analyst on a different
day and using different equipment. The RSD of combined
results obtained by both analysts was calculated to evaluate
intermediate-precision results.
2.6.5. LOD and LOQ. LOD and LOQ of florfenicol and
flunixin using this method were determined by analyzing
different dilute solutions of florfenicol and flunixin and
measuring signal-to-noise ratio.The limit of detection (LOD)
is the concentration that gives a signal-to-noise ratio of
approximately 3 : 1, while the limit of quantification (LOQ)
is the concentration that gives a signal-to-noise ratio of
approximately 10 : 1 with % RSD (𝑛 = 3) of less than 10%.
2.6.6. Robustness. Robustness was performed by applying
little deliberate changes of the following method conditions:
(i) pH of mobile phase: ±0.2
(ii) Temperature: ±5∘C
(iii) Flow rate: ±0.1mL/min
(iv) Wavelength: ±2 nm
(v) Mobile phase composition, organic composition ±5%
Sample and standard solutions were analyzed for each
change. Changewasmade to evaluate its effect on themethod.
Obtained data for each case was evaluated by calculating %
RSD and percent of recovery.
3. Results and Discussion
3.1. Method Development and Optimization. With regard to
the physical and chemical properties of the analytes and the
information obtained from the literature, analytical method
was developed to select a preliminary reversed phase HPLC-
UV chromatographic conditions, including detection wave-
length, mobile phase, stationary phase, and sample prepara-
tion procedure. For that, series of trials were performed, such
as different compositions of mobile phase and different types
of stationary phase and column lengths, with different pH
values and buffering agents.
On the basis that themethodwill be used for separation of
two analytes from each other, and also from their degradants,
the RP18e stationary phase with a 250mm length was initially
selected. According to the analytes physicochemical proper-
ties, a mixture of acetonitrile and water 50% : 50% v/v was
selected as the mobile phase, adjusted to pH 4.2 with diluted
acetic acid and a flow rate of 1.0mL/min.
Using these isocratic chromatographic conditions, first
successful effort of eluting the analytes simultaneously has
been established; the florfenicol peak symmetry and column
efficiency were good, but the flunixin peak eluted lately with
poor symmetry and column efficiency.
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Figure 2: Chromatogram of Flr and Flx in drug product using the
developed method in this study.
This required carrying out some modifications in the
mobile phase composition and its pH value. Therefore, the
ratio of the mobile phase components was changed to be
acetonitrile and water 60% : 40% v/v and the pH reduced to
3.0 by diluted acetic acid.
Good flunixin peak symmetry and column efficiency
were obtained, but the florfenicol peak was affected.
Additional chromatographic conditions were altered to
optimize the florfenicol peak, where the pH of the same
mobile phase was reduced to 2.8 by diluted phosphoric acid.
As a result of that, a satisfying analyticalmethodwas obtained
as shown in Figure 2, the resolution (𝑅) and other system
suitability parameters of the obtained peaks of florfenicol and
flunixin were excellent, as illustrated in Table 7.
Using the PDA-UV a WL of 268 nm was selected as the
optimumwavelength. Placebo (mixture of excipients) did not
show any response. Forced degradation study solutions were
analyzed using the developed method and the degradative
materials peaks were adequately separated from that of Flr
and Flx (Figures 3, 4, 5, and 6).Theoptimized conditionswere
given in Table 1.
3.2. Specificity and Stability-Indicating Study. Specificity is
the ability of the analytical method to measure the active
ingredient response in the presence of other excipients and
its potential degradants. Forced degradation was carried out
to evaluate the specificity and stability-indicating properties
of the method, by exposing samples of the drug substance
and drug product to stress conditions of hydrolysis, oxida-
tion, photodegradation, and thermal degradation as detailed
under Section 2.6.1.
Stress testing of the drug product was performed to
induce force degradation and determine degradation path-
ways and help evaluate the stability of the drug substance and
also validate specificity of the analytical procedures.
The basic condition applied on the active drug substances
for 2 hours induced the hydrolysis of florfenicol causing assay
loss of about 26% and degradativematerials (Fr1) and (Fr2) of
about 23% and 4.5%, respectively, while no degradation was
observed for flunixin.
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Figure 3: Chromatogram of stress testing of Flr and Flx under basic
hydrolysis condition of 0.02N NaOH, at RT for 2 hours.
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Figure 4: Chromatogramof stress testing of Flr and Flx under acidic
hydrolysis condition of 1 N HCl, at 40∘C for 2 days.
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Figure 5: Chromatogram of stress testing of Flr and Flx under
oxidative condition of 0.2% H
2
O
2
at 40∘C, protected from light for
7 days.
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Figure 6: Chromatogram of Flr and Flx under thermal stress testing
condition of 75∘C for 14 days.
The acidic condition applied on the active drug sub-
stances for 2 days induced the hydrolysis of florfenicol
causing assay loss of about 10.5% and degradative material
(Fr3) of about 11%, while no degradation was observed for
flunixin.
The oxidative condition applied on the active drug
substances for 7 days induced the oxidation of flunixin
causing assay loss of about 61% and degradative material
(Fx1) of about 14.5%, while no degradation was observed for
florfenicol.
The thermal condition applied on the active drug sub-
stances for 14 days induced the degradation of florfenicol
causing assay loss of about 7.5% and degradative material
(Fr4) of about 8%, while no degradation was observed for
flunixin.
Therewas no evidence of degradation of the drug product
exposed to stress condition of the photodegradation type.
These results are summarized in Table 3.
Results showed no interference between the chromato-
graphic peaks of florfenicol and flunixin and the excipients,
impurities, and degradation products under the various stress
conditions (Figures 3, 4, 5, and 6).The spectra of all the peaks
were checked using PDA showing perfect purity.
It is concluded that method of analysis is qualified and
reliable to demonstrate and detect any expected change in the
drug product assay during stability studies.
3.3. Linearity and Range. The linearity of an analytical
method can be defined as the ability of the method to obtain
test results that are directly proportional to the analyte con-
centration, within a given range. The linearity of the method
was observed in the concentration range of 480𝜇g/mL to
1920𝜇g/mL for florfenicol and 43.8 𝜇g/mL to 175.4𝜇g/mL
for flunixin demonstrating its suitability for analysis. The
goodness of fit (𝑅2)was found to be 0.9997 for each of Flr and
Flx, respectively, indicating a linear relationship between the
concentration of analyte and area under the peak, as shown
in Table 4.
3.4. Accuracy. The accuracy of an analytical procedure
expresses the closeness of results obtained by that method
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Table 3: The results of stress testing of Flr and Flx under various conditions.
Stress type Detectable change Degradation
Name Percentage
Basic hydrolysis 26% florfenicol assay lossDegradation
Fr1
Fr2
23.0%
4.5%
Acid hydrolysis 10.5% florfenicol assay lossDegradation Fr3 11.0%
Oxidative/solution 61% flunixin assay lossDegradation Fx1 14.5%
Thermal 7.5% florfenicol assay lossDegradation Fr4 8.0%
Photodegradation No change
Table 4: Regression analysis of florfenicol and flunixin.
API
Linearity
range
(𝜇g/mL)
(𝑅2) Linearity equation 𝑌-intercept
Flr 480 to 1920 0.9997 𝑦 = 0.0395𝑥 + 0.1003 0.10
Flx 43.8 to 175.4 0.9997 𝑦 = 0.3795𝑥 + 0.1361 0.13
Table 5: Evaluation of the accuracy of the method developed in this
study.
API
Spiked
level
(𝜇g/mL)
Replicate
number
Recovery
(𝜇g/mL) % mean recovery % RSD
Flr
960.0
1 960.79
99.84 0.222 957.58
3 956.90
1200.0
1 1214.99
101.10 0.152 1213.30
3 1211.35
1440.0
1 1431.03
99.43 0.072 1432.83
3 1431.33
Flx
87.7
1 87.59
99.62 0.232 87.21
3 87.29
109.6
1 110.72
100.83 0.182 110.49
3 110.33
131.5
1 130.55
99.31 0.032 130.62
3 130.60
to the true value. The results of accuracy testing showed
that the method is accurate within the acceptable limits.
The percentage recovery and RSD were calculated for both
active ingredients florfenicol and flunixin; all the results are
within limits. Acceptable accuracy was within the range of
98.0% to 102.0% recovery and not more than 2.0% RSD, as
demonstrated in Table 5.
3.5. Precision. Precision of an analytical method is defined
as “the closeness of agreement between a series of mea-
surements obtained from multiple sampling of the same
Table 6: Evaluation of precision of the method developed in this
study.
API Flr Flx
Spiked amount (𝜇g/mL) 1200 109.6
Intermediate precision (ruggedness)
Replicate number Recovery (𝜇g/mL)
Repeatability (method precision)
Day 1
1 1214.99 110.72
2 1213.30 110.49
3 1211.35 110.33
4 1210.77 110.26
5 1209.64 110.09
6 1208.75 110.10
Mean recovery 1211.47 110.33
% RSD 0.19 0.22
Day 2
1 1204.72 110.29
2 1198.82 113.07
3 1200.00 110.95
4 1202.35 110.27
5 1200.59 111.19
6 1202.35 108.61
Mean recovery 1206.47 110.53
% RSD 0.47 0.92
homogeneous sample under the prescribed conditions,” and
it is normally expressed as the relative standard deviation.
The results of repeatability and intermediate-precision
testing showed that the method is precise within the accept-
able limits. The RSD were calculated for both active ingredi-
ents florfenicol and flunixin; all the results are within limits.
Precision was not more than 2.0% RSD, as demonstrated in
Table 6.
3.6. Robustness. The robustness of the method was examined
using the minor modifications, as shown in Section 2.6.6.
The results of robustness testing showed that little change
of method conditions, such as pH of the mobile phase,
composition of the mobile phase, temperature, flow rate, and
wavelength, does not affect themethod significantly, and so it
6 Journal of Analytical Methods in Chemistry
Table 7: System suitability parameters of the current method.
Florfenicol Flunixin Acceptance criteria
Tailing factor, 𝑇 1.10 1.12 ≤2.0
Resolution, 𝑅 4.4 >2.0
Number of theoretical plates,𝑁 11500 14700 >2000
% RSD (𝑛 = 6) 0.19 0.22 ≤2.0%
is robust within the acceptable limits. Percent of recovery was
within the range of 97.0% to 103.0% and RSD was not more
than 3.0% for both active ingredients, florfenicol and flunixin.
3.7. Limit of Detection and Limit of Quantification (LOD
and LOQ). The limit of detection (LOD) is the lowest
amount of analyte in a sample that can be detected, but
not necessarily quantitated, while the limit of quantification
(LOQ) is the lowest amount of analyte in a sample that
can be quantitatively determined with suitable precision.The
method showed a LOD of 0.60 and 0.20𝜇g/mL for florfenicol
and flunixin, respectively, and showed a LOQ of 2.4 and
0.40 𝜇g/mL for florfenicol and flunixin, respectively, with a
RSD (𝑛 = 3) of 2.4% and 2.6% for florfenicol and flunixin,
respectively.
3.8. System Suitability. System suitability parameters were
performed using six replicates of a standard solution contain-
ing both florfenicol and flunixin, to verify the analytical sys-
tem performance. The method shows that the % RSD values
are not more than 2.0% for both florfenicol and flunixin, and
all the values for the system suitability parameters such as
the column efficiency, the tailing factors, and the resolution
values, as presented in Table 7, are within limits.
3.9. Solution Stability. The stability of solutions was per-
formed at room temperature, by the assay analysis at regular
intervals. The solution was tested every 2 hours from the
beginning to 16 hours.The percent of recovery was within the
range of 98.0% to 102.0% andRSDwas notmore than 2.0% for
both active ingredients, florfenicol and flunixin, indicating a
good stability of sample and standard solutions for 16 hrs.
4. Conclusion
A fast, simple, accurate, precise, and linear stability-
indicating HPLC method has been developed and validated
for the simultaneous analysis of florfenicol and flunixin
in a pharmaceutical formulation. The method is stability
indicating and reliable to detect and quantify any potential
degradation in the drug product during stability studies and
can be used for routine quality control analysis. The method
is robust enough to reproduce accurate and precise results
under different chromatographic conditions.
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